GlaxoSmithKline (GSK)
Summary
Sector: Pharmaceuticals & Biotechnology
Indices: FTSE All-Share | FTSE Eurotop 300 | techMARK | FTSE 100
Currency: UK Pounds
| Bid Price: | 1175.5p | Volume: | 9,339,606 |
| Mid Price: | 1175.5p | Market Cap: | 60,793.21m |
| Offer Price: | 1176p | 52 Wk High/Low: | 1,385.00p / 994.99p |
| Prev Close Price: | 1170p | Shares in Issue: | 5,197m |
| Change Today: |  5.5p (0.47%) | Updated: | 16:20 |
GlaxoSmithKline: Company Overview
UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Latest Announcements from GlaxoSmithKline
| 02/12/2008 | 17:23 | Transaction in Own Shares |
| 01/12/2008 | 18:07 | Transaction in Own Shares |
| 01/12/2008 | 16:59 | Total Voting Rights |
| 27/11/2008 | 17:05 | Transaction in Own Shares |
| 26/11/2008 | 17:28 | Transaction in Own Shares |
Latest News featuring GlaxoSmithKline
| 28/11/2008 | 11:40 | Sector movers: Miners in a hole |
| 21/11/2008 | 14:15 | London afternoon: Utilities out of favour |
| 21/11/2008 | 12:08 | London midday: Banks and miners lift Footsie |
| 21/11/2008 | 10:19 | London midmorning: Footsie posting big gains |
| 18/11/2008 | 13:06 | Sector movers: Oil services groups' fortunes turn |
Latest GlaxoSmithKline Trades
| Date | Time | Buy/Sell | Price | Volume | Type (key) |
| 03/12/2008 | 17:02:06 | Sell | 1112.00p | 85000 | Ordinary Trade |
| 03/12/2008 | 16:54:31 | Sell | 1127.50p | 128 | Ordinary Trade |
| 03/12/2008 | 16:46:00 | Sell | 1170.00p | 11700 | IF |
| 03/12/2008 | 16:42:00 | Sell | 1170.00p | 60200 | IF |
| 03/12/2008 | 16:35:01 | Buy | 1170.00p | 2874367 | Uncrossing Trade |
| 03/12/2008 | 16:29:52 | Sell | 1169.50p | 200 | Automatic Trade |
Latest GlaxoSmithKline Director Dealings
| Date | Notifier | Buy/Sell | Price | Volume |
GlaxoSmithKline Financial Overview
| Year End : | 31 December 2007 |
| Turnover : | £22,716m |
| Profit / Loss : | £7,593m |
GlaxoSmithKline Key Personnel & Dates
| CFO: | Julian Heslop |
| CEO: | Andrew P Witty |
| Final Results: | 13 February 2008 |
| Int. Results: | 26 July 2006 |
| AGM: | 21 May 2008 |
All data suppied by Digital Look (15 minute delay)
There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.
The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.